Articles: 26.17 5 September 2015

Challenging treatment thresholds

National organisations such as NICE or American College of Cardiology (ACC)/American Heart Association (AHA) regularly release cardiovascular disease (CVD) guidelines that recommend lifestyle and medication interventions along with treatment thresholds based either on risk factors or calculated CVD risks.
Challenging treatment thresholds

More details...

Guidance on CCG quality premium payments

Quality premium payments reward CCGs for improvements in services provision and patient outcomes, while requiring them to deliver good financial management. Here we examine the guidance from NHS England on achieving this.
Guidance on CCG quality premium payments

More details...

If we understand the past we can plan for the future

Tracing the history of prescribing in the UK and why it matters in present day dispensing.
If we understand the past we can plan for the future

More details...

Managing hypertension and meeting targets

Despite constantly updated guidelines and a wide choice of drugs for hypertension only 37 per cent of patients have their blood pressure (BP) adequately controlled. This article give practical tips on how best to achieve the targets for BP control using current guidelines.
Managing hypertension and …

More details...

Spending on cessation therapies decreasing but 1 in 5 still smoke

Here we summarise the key points from the Health and Social Care Information Centre’s report on smoking in England during 2014.
Spending on cessation therapies decreasing but 1 in 5 still smoke

More details...

Treating status epilepticus in the community

Early treatment of status epilepticus is vital so it is important to identify those patients at risk. Carers can then be trained to use buccal midazolam where possible for early intervention.
Treating status epilepticus in the community

More details...

Xultophy: combination therapy for the treatment of type 2 diabetes

Xultophy is the first product to combine a basal insulin and an incretin mimetic for the treatment of type 2 diabetes. Here Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Vinod Patel outlines its place in therapy.
Xultophy combination therapy …

More details...

Web design and marketing agency Leamington Spa